Feed DXCM
DX

DexCom DXCM · NASDAQ

$86.04 -1.90% (-$1.67)

Market cap
$33.1B
Enterprise value
$33.4B
P/E
33.1x
Forward P/E
32.5x
PEG
0.9x
P/S
6.7x
P/FCF
23.6x
EV/EBITDA
21.4x
ROIC
21.6%
Bruto marža
62.5%
Neto marža
20.1%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
0.2x
Beta
1.48
Free float
99.6%

O podjetju

DexCom, Inc. (DXCM) is an American healthcare company specializing in the development and production of continuous glucose monitoring (CGM) systems for patients with diabetes. With innovative products like the Dexcom G6, DexCom provides accurate and continuous monitoring of blood sugar levels, allowing patients and healthcare professionals to better manage diabetes and improve quality of life. The company is known for its focus on technological innovations and continuous improvement of its products. DexCom also collaborates with other healthcare companies to integrate its CGM systems into broader healthcare ecosystems. DexCom, Inc. (DXCM) shares could be suitable for investors looking for opportunities in the medical technology sector with a focus on diabetes and innovations in health monitoring.

Sector

Healthcare

Industry

Medical - Devices

CEO

Jacob Steven Leach

Employees

11,050

Headquarters

San Diego

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

Finančno zdravje

Ali zmore svoj dolg?

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.